To determine whether hyperglycemia in brain-dead donors is a sign of e
ndocrine pancreas insufficiency, we studied pancreatic function in 25
consecutive brain dead patients. Blood samples were drawn at 2-hr inte
rvals from donor referral until organ procurement to analyze glucose,
insulin, and C-peptide levels. After donor retrieval, two specimens we
re taken from the pancreas for a subsequent immunohistochemical examin
ation. At referral mean glycemia was 13.60+/-1.49 mmol/L, and there wa
s a large range of plasma glucose levels (4.631. 6). Of 25 patients, 1
6 had glycemia above 10 mmol/L. At organ procurement a mean of 20 hr l
ater, mean glycemia as 8.61+/-0.58 mmol/L (P<0.005 with paired t test)
, and only 5 patients had glycemia above 10 mmol/L. Hyperglycemia was
associated with elevated insulin and C-peptide levels during donor man
agement. An elevated C-peptide/glucose molar ratio might be considered
a sign of peripheral insulin resistance. Hyperglycemia above 25 mmol/
L could not be related to the amount of glucose administered during do
nor maintenance. Severe hyperglycemia had a natural tendency to be par
tly corrected. Histologic and immunohistochemical examinations were av
ailable in 17 cases and can be considered normal. It is concluded that
endocrine pancreatic function can be considered effective after brain
death. The mechanism of the relative insulin resistance of these pati
ents requires further study. Blood glucose levels, in the range observ
ed in this study, are not a good donor criterion of endocrine pancreat
ic function before pancreas transplantation.